Noxopharm Limited Profit Margin

The latest profit margin for NOXOF is -331.11% as of June 2026. That compares with -205.47% in the prior-year period — down 61.1% year over year. That is below the Healthcare sector average of 10.58%. Investors often review this figure alongside Noxopharm Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, NOXOF's profit margin moved from -205.47% to -331.11% — a 61.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Noxopharm Limited's valuation or profitability profile.

Against Healthcare companies, NOXOF currently prints -331.11% for profit margin, while the sector average sits near 10.58%. That is roughly 3229.4% below the sector mean. Large gaps often invite a closer look at Noxopharm Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Noxopharm Limited converts resources into returns. At -331.11%, NOXOF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -205.47% in the prior-year period — down 61.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting NOXOF's profit margin (-331.11%), review year-over-year change from -205.47%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.